Inhaler safety results differ between independent, company trials

11/14/2007 | NYTimes.com

Independent studies on inhaled corticosteroids are more likely to find adverse side effects than company-funded trials, a review of more than 500 studies found. Randomized clinical trials not funded by drug companies were two and a half times as likely to find such side effects, indicating that the study design may influence findings about the treatment's adverse effects.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD